ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory…
AndyJanuary 4, 2024
Maryland biotechnology company promotes improved patient outcomes for infants with body deformities COLUMBIA, Md. (January 3, 2024) – TEDCO, Maryland’s economic engine…
AndyJanuary 4, 2024
FDA IDE approval of Sonavex's randomized trial comes months after meeting the endpoint of its first clinical study BALTIMORE, Jan. 2,…
AndyJanuary 2, 2024
The U.S. National Science Foundation today announced the first-ever Accelerating Research Translation (ART) investment — more than $100 million to…
AndyJanuary 2, 2024
In this episode of BioTalk with Rich Bendis, we’re joined by three guests from Solaxa: CEO & Founder Christian Walker,…
AndyJanuary 1, 2024
In this episode of BioTalk with Rich Bendis, we’re joined by three guests from Solaxa: CEO & Founder Christian Walker,…
AndyJanuary 1, 2024
Sue Carr clearly remembers the moment that pushed her to become a full-time entrepreneur. In 2018, Carr was working at…
AndyDecember 29, 2023
The year “gaslighting” of women with hard-to-diagnose maladies was finally given the kabosh? The year we found the hormone causing…
AndyDecember 29, 2023
CEPI to invest funding of up to $34.8 million to Barinthus Bio in addition to funds previously committed to the…
AndyDecember 21, 2023